Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-3-6
|
pubmed:abstractText |
A patient from the Caribbean area with active T-cell lymphoma-leukaemia was primarily treated with deoxycoformycin (DCF), 5 mg/m2 i.v. on 3 consecutive days, followed by 5 mg/m2 i.v. weekly. A complete remission was attained and maintained during several weeks with DCF. A single consolidation course with other cytostatics was then given. The patient continues in complete remission without further therapy, 24 months after diagnosis, 17 months after the last cytostatic drugs. T-cell lymphoma-leukaemia has a bad prognosis with conventional anti-lymphoma therapy but was exquisitely sensitive to DCF in this patient.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
723-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6097297-Adult,
pubmed-meshheading:6097297-Antineoplastic Agents,
pubmed-meshheading:6097297-Coformycin,
pubmed-meshheading:6097297-Deltaretrovirus,
pubmed-meshheading:6097297-Drug Administration Schedule,
pubmed-meshheading:6097297-Female,
pubmed-meshheading:6097297-Humans,
pubmed-meshheading:6097297-Leukemia,
pubmed-meshheading:6097297-Lymphoma,
pubmed-meshheading:6097297-Pentostatin,
pubmed-meshheading:6097297-Retroviridae Infections,
pubmed-meshheading:6097297-Ribonucleosides,
pubmed-meshheading:6097297-T-Lymphocytes
|
pubmed:year |
1984
|
pubmed:articleTitle |
Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia.
|
pubmed:publicationType |
Journal Article,
Case Reports
|